Semaphorin 4D抑制中性粒细胞活化并参与中性粒细胞介导的自身免疫性血管炎发病机制
该研究探讨了semaphorin 4D(SEMA4D)在中性粒细胞活化调控及ANCA相关血管炎(AAV)发病中的作用。AAV患者血清可溶性SEMA4D升高且与疾病活动评分相关,中性粒细胞表面SEMA4D表达下调源于膜蛋白水解切割。中性粒细胞膜SEMA4D与内皮细胞plexin B2结合可减少NET形成,重组plexin B2通过SEMA4D胞内域抑制Rac1活化及病原或ANCA诱导的氧化爆发和NET形成。SEMA4D是AAV有前景的生物标志物和潜在治疗靶点。
要点
- AAV患者血清可溶性SEMA4D升高,与疾病活动评分相关
- 中性粒细胞表面SEMA4D下调源于膜蛋白水解切割,可放大炎症反应
- 中性粒细胞膜SEMA4D与内皮plexin B2结合减少NET形成
核心结论
- 中性粒细胞表面SEMA4D是中性粒细胞活化的负调控因子。
- AAV患者中观察到的SEMA4D蛋白水解切割可能放大中性粒细胞介导的炎症反应。
- SEMA4D是AAV有前景的生物标志物和潜在治疗靶点。
研究设计与样本
- 采用ELISA检测血清可溶性SEMA4D水平,流式细胞术检测血细胞表面膜SEMA4D表达。
- 将野生型和SEMA4D-/-小鼠中性粒细胞与经SYTOX green染色的内皮细胞系MS1共培养,进行中性粒细胞胞外诱捕网(NET)形成实验。
- 用重组plexin B2处理人中性粒细胞,通过动力学氧化爆发和NET形成实验评估疗效。
主要发现
- AAV患者血清可溶性SEMA4D水平升高,且与疾病活动评分相关。
- AAV患者中性粒细胞表面SEMA4D表达下调,是膜SEMA4D蛋白水解切割的结果。
- 可溶性SEMA4D对内皮细胞发挥促炎效应。
- 中性粒细胞膜SEMA4D与内皮细胞plexin B2结合,该相互作用减少NET形成。
- 重组plexin B2通过SEMA4D胞内域抑制中性粒细胞Rac1活化,并抑制病原诱导或ANCA诱导的氧化爆发和NET形成。
临床怎么用
- 血清可溶性SEMA4D可作为AAV疾病活动度的潜在生物标志物。
- 靶向SEMA4D或其通路(如重组plexin B2)可能成为抑制中性粒细胞过度活化的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Inappropriate activation of neutrophils plays a pathological role in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The aim of this study was to investigate the functions of semaphorin 4D (SEMA4D) in regulation of neutrophil activation, and its involvement in AAV pathogenesis. METHODS: Serum levels of soluble SEMA4D were evaluated by ELISA. Blood cell-surface expression of membrane SEMA4D was evaluated by flow cytometry. To determine the functional interactions between neutrophil membrane SEMA4D and endothelial plexin B2, wild-type and SEMA4D-/- mice neutrophils were cultured with an endothelial cell line (MS1) stained with SYTOX green, and subjected to neutrophil extracellular trap (NET) formation assays. The efficacy of treating human neutrophils with recombinant plexin B2 was assessed by measuring the kinetic oxidative burst and NET formation assays. RESULTS: Serum levels of soluble SEMA4D were elevated in patients with AAV and correlated with disease activity scores. Cell-surface expression of SEMA4D was downregulated in neutrophils from patients with AAV, a consequence of proteolytic cleavage of membrane SEMA4D. Soluble SEMA4D exerted pro-inflammatory effects on endothelial cells. Membranous SEMA4D on neutrophils bound to plexin B2 on endothelial cells, and this interaction decreased NET formation. Recombinant plexin B2 suppressed neutrophil Rac1 activation through SEMA4D's intracellular domain, and inhibited pathogen-induced or ANCA-induced oxidative burst and NET formation. CONCLUSIONS: Neutrophil surface SEMA4D functions as a negative regulator of neutrophil activation. Proteolytic cleavage of SEMA4D as observed in patients with AAV may amplify neutrophil-mediated inflammatory responses. SEMA4D is a promising biomarker and potential therapeutic target for AAV.
引用
- Nishide M, Nojima S, Ito D, et al. Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. Ann Rheum Dis. 2017. PMID: 28416516. doi:10.1136/annrheumdis-2016-210706
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。